The impact of initial antibiotic treatment failure: real-world insights in patients with complicated, health care-associated intra-abdominal infection

References

• SartelliMA focus on intra-abdominal infectionsWorld J Emerg Surg20105920302628
   PubMed Web of Science ®Google Scholar
• KollefMHNapolitanoLMSolomkinJSHealth care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI SummitClin Infect Dis200847Suppl 2S55S9918778223
   PubMed Web of Science ®Google Scholar
• LopezNKobayashiLCoimbraRA comprehensive review of abdominal infectionsWorld J Emerg Surg20116721345232
   PubMed Web of Science ®Google Scholar
• ZhangSHuangWEpidemiological study of community- and hospital-acquired intraabdominal infectionsChin J Traumatol2015182848926511299
   PubMedGoogle Scholar
• SartelliMCatenaFAnsaloniLComplicated intra-abdominal infections in Europe: a comprehensive review of the CIAO studyWorld J Emerg Surg2012713623190741
   PubMed Web of Science ®Google Scholar
• PieracciFMBariePSManagement of severe sepsis of abdominal originScand J Surg200796318419617966743
   PubMed Web of Science ®Google Scholar
• SartelliMWeberDGRuppéEAntimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)World J Emerg Surg2016113327429642
   PubMed Web of Science ®Google Scholar
• KanjSSKanafaniZACurrent concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Entero-bacteriaceae, and multidrug-resistant Pseudomonas aeruginosaMayo Clin Proc201186325025921364117
   PubMed Web of Science ®Google Scholar
• MorrisseyIHackelMBadalRBouchillonSHawserSBiedenbachDA review of ten years of the study for monitoring antimicrobial resistance trends (SMART) from 2002 to 2011Pharmaceuticals20136111335134624287460
   PubMedGoogle Scholar
• Munoz-PriceLSPoirelLBonomoRAClinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemasesLancet Infect Dis201313978579623969216
   PubMed Web of Science ®Google Scholar
• DellitTHOwensRCMcGowanJEInfectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardshipClin Infect Dis200744215917717173212
   PubMed Web of Science ®Google Scholar
• SartelliMVialePCatenaF2013 WSES guidelines for management of intra-abdominal infectionsWorld J Emerg Surg201381323294512
   PubMed Web of Science ®Google Scholar
• BabinchakTBadalRHobanDTrends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005–2010Diagn Microbiol Infect Dis201376337938123541118
   PubMed Web of Science ®Google Scholar
• EckmannCDrydenMMontraversPKozlovRSgangaGAntimicrobial treatment of “complicated” intra-abdominal infections and the new IDSA guidelines? A commentary and an alternative European approach according to clinical definitionsEur J Med Res201116311512621486724
   PubMed Web of Science ®Google Scholar
• HawkeyPMMultidrug-resistant Gram-negative bacteria: a product of globalizationJ Hosp Infect201589424124725737092
   PubMed Web of Science ®Google Scholar
• KollefMHShermanGWardSFraserVJInadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patientsChest1999115246247410027448
   PubMed Web of Science ®Google Scholar
• KumarARobertsDWoodKEDuration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shockCrit Care Med20063461589159616625125
   PubMed Web of Science ®Google Scholar
• ZilberbergMDShorrAFMicekSTVazquez-GuillametCKollefMHMulti-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort studyCrit Care201418659625412897
   PubMed Web of Science ®Google Scholar
• RamanGAvendanoEBergerSMenonVAppropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysisBMC Infect Dis20151539526423743
   PubMed Web of Science ®Google Scholar
• LucastiCHershbergerEMillerBMulticenter, double-blind, randomized, Phase II trial to assess the safety and efficacy of ceftolozane–tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infectionsAntimicrob Agents Chemother20145895350535724982069
   PubMed Web of Science ®Google Scholar
• MazuskiJEGasinkLBArmstrongJEfficacy and safety of ceftazidime–avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, Phase 3 programClin Infect Dis201662111380138926962078
   PubMed Web of Science ®Google Scholar
• SartelliMCatenaFAnsaloniLComplicated intra-abdominal infections worldwide: the definitive data of the CIAOW StudyWorld J Emerg Surg201493724883079
   PubMed Web of Science ®Google Scholar
• SolomkinJHershbergerEMillerBCeftolozane/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, Phase 3 trial (ASPECT-cIAI)Clin Infect Dis201560101462147125670823
   PubMed Web of Science ®Google Scholar
• MazuskiJETessierJMMayAKThe Surgical Infection Society revised guidelines on the management of intra-abdominal infectionSurg Infect (Larchmt)201718117628085573
   PubMed Web of Science ®Google Scholar
• MurrayBEThe life and times of the EnterococcusClin Microbiol Rev19903146652404568
   PubMed Web of Science ®Google Scholar
• MagiorakosAPSrinivasanACareyRBMultidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClin Microbiol Infect201218326828121793988
   PubMed Web of Science ®Google Scholar
• SartelliMVialePKoikeKWSES consensus conference: guidelines for first-line management of intra-abdominal infectionsWorld J Emerg Surg20116221232143
   PubMed Web of Science ®Google Scholar
• GolanYEmpiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment optionsBMC Infect Dis20151531326243291
   PubMed Web of Science ®Google Scholar
• RattanRAllenCJSawyerRGPatients with complicated intra-abdominal infection presenting with sepsis do not require longer duration of antimicrobial therapyJ Am Coll Surg2016222444044626920994
   PubMed Web of Science ®Google Scholar
• SawyerRGClaridgeJANathensABTrial of short-course antimicrobial therapy for intraabdominal infectionN Engl J Med2015372211996200525992746
   PubMed Web of Science ®Google Scholar